CA2744142A1 - Directly compressible granular microcrystalline cellulose based excipient, manufacturing process and use thereof - Google Patents

Directly compressible granular microcrystalline cellulose based excipient, manufacturing process and use thereof Download PDF

Info

Publication number
CA2744142A1
CA2744142A1 CA2744142A CA2744142A CA2744142A1 CA 2744142 A1 CA2744142 A1 CA 2744142A1 CA 2744142 A CA2744142 A CA 2744142A CA 2744142 A CA2744142 A CA 2744142A CA 2744142 A1 CA2744142 A1 CA 2744142A1
Authority
CA
Canada
Prior art keywords
binder
excipient
microcrystalline cellulose
slurry
disintegrant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2744142A
Other languages
English (en)
French (fr)
Inventor
Nandu Deorkar
James Farina
Liliana Miinea
Sameer Randive
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Avantor Performance Materials LLC
Original Assignee
Avantor Performance Materials LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avantor Performance Materials LLC filed Critical Avantor Performance Materials LLC
Publication of CA2744142A1 publication Critical patent/CA2744142A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
CA2744142A 2008-11-19 2009-11-16 Directly compressible granular microcrystalline cellulose based excipient, manufacturing process and use thereof Abandoned CA2744142A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11602508P 2008-11-19 2008-11-19
US61/116,025 2008-11-19
PCT/US2009/064498 WO2010059534A2 (en) 2008-11-19 2009-11-16 Directly compressible granular microcrystalline cellulose based excipient, manufacturing process and use thereof

Publications (1)

Publication Number Publication Date
CA2744142A1 true CA2744142A1 (en) 2010-05-27

Family

ID=42077071

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2744142A Abandoned CA2744142A1 (en) 2008-11-19 2009-11-16 Directly compressible granular microcrystalline cellulose based excipient, manufacturing process and use thereof

Country Status (13)

Country Link
US (1) US20110288146A1 (enExample)
EP (1) EP2376067A2 (enExample)
JP (1) JP2012509329A (enExample)
KR (1) KR20110089180A (enExample)
CN (1) CN102215825A (enExample)
AU (1) AU2009316812A1 (enExample)
BR (1) BRPI0921507A2 (enExample)
CA (1) CA2744142A1 (enExample)
IL (1) IL212955A0 (enExample)
MX (1) MX2011005168A (enExample)
SG (1) SG171752A1 (enExample)
TW (1) TW201023897A (enExample)
WO (1) WO2010059534A2 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101298788B1 (ko) * 2011-03-15 2013-08-22 보령제약 주식회사 안정성이 개선된 복합제제
MY169160A (en) * 2012-04-27 2019-02-19 Japan Corn Starch Co Ltd Method for producing starch granules, and orally disintegrating tablet
DK2968529T3 (da) 2013-03-14 2020-10-12 Aimmune Therapeutics Inc Fremstilling af jordnøddeformuleringer til oral desensibilisering
US9492535B2 (en) 2013-03-14 2016-11-15 Aimmune Therapeutics, Inc. Peanut formulations and uses thereof
WO2015187736A1 (en) * 2014-06-02 2015-12-10 Allergen Research Corporation Placebo formulations and uses thereof
CN104189915B (zh) * 2014-07-30 2016-08-10 上海新亚药业闵行有限公司 一种固体制剂预混剂及其制备方法
CN104258411A (zh) * 2014-09-19 2015-01-07 安徽山河药用辅料股份有限公司 一种硅化微晶纤维素复合辅料及其制备方法
CN106265077A (zh) * 2015-05-30 2017-01-04 天士力制药集团股份有限公司 一种中药浸膏雾化分散工艺及其制剂
JP6650750B2 (ja) * 2015-12-22 2020-02-19 アサヒグループ食品株式会社 錠剤の製造方法、錠剤原料用顆粒の製造方法、及び錠剤原料用顆粒
EP3836801A4 (en) 2018-08-16 2022-05-18 Société des Produits Nestlé S.A. MAINTENANCE DOSE ORAL PEANUT IMMUNOTHERAPY
JP2022514645A (ja) 2018-12-20 2022-02-14 アイミューン セラピューティクス，インコーポレイテッド ピーナツ経口免疫療法において投与が欠落した場合の投与スケジュール
CN113966229A (zh) 2019-05-10 2022-01-21 爱沐疗法公司 用于改善花生过敏患者的生活质量的方法
PH12021553026A1 (en) 2019-07-05 2023-08-23 Swedish Match North Europe Ab An oral pouched nicotine product including a filling material comprising nicotine-containing particles
KR102849937B1 (ko) 2019-11-20 2025-08-25 스웨디쉬 매치 노스 유럽 에이비 니코틴 입자를 포함하는 충전 재료를 포함하는 경구 파우치형 니코틴 제품
EP4018848B1 (en) 2020-12-22 2024-09-18 Swedish Match North Europe AB A pouched product for oral use comprising a liquid permeable cover material and a filling material
CN116036291B (zh) * 2022-08-31 2025-08-26 瑞普（天津）生物药业有限公司 一种具有增溶作用的组合物及其制备方法与应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3505433A1 (de) * 1985-02-16 1986-08-21 Basf Ag, 6700 Ludwigshafen Direkttablettierhilfsmittel
EP0619731B1 (en) * 1991-12-30 2000-10-04 Fmc Corporation Microcrystalline cellulose spheronization composition
US5686107A (en) * 1995-01-30 1997-11-11 Fmc Corporation Chewable pharmaceutical tablets
DE19628617A1 (de) * 1996-07-16 1998-01-22 Basf Ag Direkttablettierhilfsmittel
EP1070740B1 (de) * 1999-07-19 2008-01-02 fit GmbH Coprozessiertes Polysaccharidprodukt mit unlöslicher Carboxymethylcellulose
CA2427991C (en) * 2000-11-06 2008-01-22 Asahi Kasei Kabushiki Kaisha Cellulose particles for pharmaceuticals
BR0206979A (pt) * 2001-02-05 2004-04-20 Scherer Technologies Inc R P Métodos e composições para reduzir o paladar de agentes farmaceuticamente ativos
EA013867B1 (ru) * 2005-02-03 2010-08-30 Никомед Фарма Ас Способ получения гранулята, содержащего карбонат кальция
WO2008020990A1 (en) * 2006-08-09 2008-02-21 Mallinckrodt Baker, Inc. New direct compressible excipient blend
EP2076249A2 (en) * 2006-10-27 2009-07-08 FMC Corporation Dry granulation binders, products, and use thereof
CN101820863A (zh) * 2007-10-10 2010-09-01 马林克罗特贝克公司 直接可压制的高功能性颗粒状微晶纤维素基赋形剂、其制备方法和用途

Also Published As

Publication number Publication date
WO2010059534A2 (en) 2010-05-27
MX2011005168A (es) 2011-05-30
WO2010059534A3 (en) 2011-01-20
AU2009316812A1 (en) 2011-07-07
KR20110089180A (ko) 2011-08-04
CN102215825A (zh) 2011-10-12
US20110288146A1 (en) 2011-11-24
SG171752A1 (en) 2011-07-28
EP2376067A2 (en) 2011-10-19
JP2012509329A (ja) 2012-04-19
IL212955A0 (en) 2011-07-31
TW201023897A (en) 2010-07-01
BRPI0921507A2 (pt) 2016-01-19

Similar Documents

Publication Publication Date Title
US20110288146A1 (en) Directly compressible granular microcrystalline cellulose based, excipient, manufacturing process and use thereof
US20170112768A1 (en) Directly compressible granular microcrystalline cellulose based excipient, manufacturing process and use thereof
US20110229527A1 (en) Directly compressible high functionality granular dibasic calcium phosphate based co-processed excipient
US10071059B2 (en) Co-processed tablet excipient composition its preparation and use
TW202245778A (zh) 藥物組成物
EP2207533B1 (en) Directly compressible high functionality granular microcrystalline cellulose based excipient, manufacturing process and use thereof
US20120100211A1 (en) Material and process for incorporation of low dosage active pharmaceutical ingredients and use thereof
HK40130660A (zh) 包含具有g12c突变的k-ras蛋白的抑制剂的固体调配物以及制备方法
CN116782888A (zh) 药物组合物

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20140911

FZDE Discontinued

Effective date: 20161116